P/E at 64.22 vs Industry's 62.33: What the Data Shows for Apollo Hospitals Enterprise Ltd.

Valuation Picture: Premium Reflecting Sector Leadership

The current P/E of 64.22 for Apollo Hospitals Enterprise Ltd. stands slightly above the hospital industry average of 62.33. This premium, while not extreme, suggests investors are willing to pay a higher multiple for the company’s earnings relative to its peers. Such a valuation often reflects expectations of superior earnings growth or a stronger market position within the sector. However, the premium is modest enough to warrant a closer look at whether the stock’s recent performance justifies this valuation.

Performance Across Timeframes: Consistent Outperformance

Examining returns over various periods, Apollo Hospitals Enterprise Ltd. has delivered robust gains. The one-year return stands at 14.89%, significantly outperforming the Sensex’s negative 8.48% over the same period. This outperformance extends to the year-to-date figure, where the stock has gained 15.36% compared to the Sensex’s decline of 11.37%. Even over longer horizons, the stock’s returns are impressive: a three-year return of 75.62% versus the Sensex’s 21.14%, a five-year return of 158.75% against 54.99%, and a remarkable ten-year return of 513.60% compared to 196.31% for the benchmark.

Shorter-term momentum also remains positive. Over the past three months, the stock has risen 7.77%, while the Sensex fell 8.59%. The one-month and one-week returns of 6.25% and 0.36% respectively further underscore the stock’s resilience. Even on the day of analysis, the stock edged up 0.10%, slightly underperforming the Sensex’s 0.17% gain but still maintaining positive momentum. This steady performance across timeframes highlights the stock’s relative strength within the hospital sector — Apollo Hospitals Enterprise Ltd. has been gaining for two consecutive days, accumulating a 3.11% return in that period.

Moving Average Configuration: Bullish Technical Setup

From a technical perspective, Apollo Hospitals Enterprise Ltd. is trading above all key moving averages — the 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. This configuration is typically indicative of a strong uptrend and suggests that the stock is in a sustained recovery or continuation phase rather than a temporary bounce. The fact that the stock hit a new 52-week and all-time high of Rs. 8,249.95 on the day of analysis further confirms the bullish technical momentum. The stock’s opening and trading price at this high level signals strong investor confidence and demand.

Sector Context: Hospital Industry Performance

The hospital sector has experienced mixed results recently, with some companies facing headwinds while others have shown resilience. Against this backdrop, Apollo Hospitals Enterprise Ltd. stands out as a consistent outperformer. Its ability to maintain gains across short and long-term periods contrasts with the sector’s more volatile performance. This relative strength may explain the slight premium in valuation, as investors appear to favour companies demonstrating steady growth and robust fundamentals within the healthcare space.

Rating Context: Previously Rated Hold, Now Reassessed

MarketsMOJO had previously assigned a Hold rating to Apollo Hospitals Enterprise Ltd.. The rating was updated on 11 May 2026, reflecting a reassessment of the company’s fundamentals and market position. While the current rating is not disclosed, the change signals a shift in the analytical view based on recent data. The valuation premium combined with strong multi-period performance and a bullish technical setup likely influenced this reassessment — Apollo Hospitals Enterprise Ltd. previously rated Hold, what is its current rating?

Collective Data Insights: Balancing Valuation and Momentum

The data presents a compelling narrative for Apollo Hospitals Enterprise Ltd.. Its P/E ratio at 64.22, slightly above the industry average, suggests investors are pricing in continued growth and sector leadership. The stock’s consistent outperformance across one-day, one-week, one-month, three-month, and longer-term horizons confirms strong momentum. The technical picture, with the stock trading above all major moving averages and hitting new highs, supports the view of a sustained uptrend rather than a short-lived rally. The hospital sector’s mixed performance further highlights Apollo Hospitals Enterprise Ltd. as a relative outperformer.

However, the premium valuation invites scrutiny — Apollo Hospitals Enterprise Ltd. trades at over 1x the sector P/E, raising the question of whether the current price fully reflects the risks and opportunities ahead. The reassessment of the rating from Hold indicates that analysts have recognised these dynamics, but Apollo Hospitals Enterprise Ltd. investors may still ask: should they hold, buy more, or reconsider their position?

Conclusion: Data-Driven Perspective on Apollo Hospitals Enterprise Ltd.

In summary, Apollo Hospitals Enterprise Ltd. exhibits a valuation premium that aligns with its strong performance record and technical strength. The stock’s ability to outperform the Sensex and maintain gains across multiple timeframes, combined with a bullish moving average configuration, underscores its leadership in the hospital sector. The reassessment of its rating from Hold reflects these evolving fundamentals and market conditions. Yet, the premium valuation invites ongoing analysis — what is the current rating, and how should investors interpret this data?

Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Start Today